US expected roll out new COVID-19 booster vaccines in September as 'Eris' variant rises
- A new COVID-19 booster vaccine, targeting the XBB.1.5 variant, is expected to be available in the US in September as hospitalizations rise from the EG.5 "Eris" variant, a descendant of the XBB lineage.
- Demand for the vaccine has dropped sharply since 2021, and health experts anticipate that the booster shots may be met with skepticism and declining concern about the virus, posing challenges for the vaccination campaign.
- The US approach to vaccination will shift from government-bought supplies to making the booster shots available in the commercial market.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left2Leaning Right4Center4Last UpdatedBias Distribution40% Center, 40% Right
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
40% Center
L 20%
C 40%
R 40%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage